Skip to main content
Journey Medical Corp logo

Journey Medical Corp — Investor Relations & Filings

Ticker · DERM ISIN · US48115J1097 US Manufacturing
Filings indexed 200 across all filing types
Latest filing 2026-04-21 Regulatory Filings
Country US United States of America
Listing US DERM

About Journey Medical Corp

https://journeymedicalcorp.com/

Journey Medical Corp. is a commercial-stage pharmaceutical company focused on developing and commercializing products for dermatological conditions. The company's business model centers on strategically identifying, acquiring, and marketing innovative and differentiated therapies to address unmet needs in skin health. Its product portfolio targets a range of conditions, including acne, rosacea, axillary hyperhidrosis (excessive sweating), fungal infections, and skin wounds. Marketed products in its portfolio include Qbrexza, Accutane, Amzeeq, and Zilxi. The company is committed to providing effective treatments that positively impact the well-being of patients with skin-related issues.

Recent filings

Filing Released Lang Actions
8-K - Journey Medical Corp (0001867066) (Filer)
Regulatory Filings
2026-04-21 English
424B3
Prospectus
2026-01-23 English
424B3
Prospectus
2026-01-23 English
Regulatory Filings 2026
Regulatory Filings
2026-01-22 English
FORM S-3
Registration Form
2026-01-15 English
Regulatory Filings 2025
Regulatory Filings
2025-12-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.